Expertise in
12
conditions

Christophe M. Pison

Grenoble, FR 
Expertise in
12
conditions
Grenoble, FR 
OverviewLocationsClinical Research

Overview

Christophe Pison practices in Grenoble, France. Mr. Pison is highly rated in 12 conditions, according to our data. His top areas of expertise are Bronchiolitis Obliterans, Chronic Obstructive Pulmonary Disease (COPD), Bronchitis, Lung Transplant, and Endoscopy.

His clinical research consists of co-authoring 145 peer reviewed articles and participating in 12 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender
Male

Locations

Grenoble, France
Other Locations
Pôle Thorax Et Vaisseaux, Av. Des Maquis Du Grésivaudan, La Tronche, 38700, France
CHRU Tours
Tours, France
Le Plessis, 92350, France
Toulouse, France
Lyon, France
Pneumologie, RCH, BP 217, St Julien De Ratz, Sete, 38043, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

12 Clinical Trials

PREdiction of Chronic LUng Allograft Dysfunction
PREdiction of Chronic LUng Allograft Dysfunction
Enrollment Status: Active_not_recruiting
Publish Date: May 16, 2025
Cardiac Function and Exercise Capacity in Pulmonary Arterial Hypertension
Cardiac Function and Exercise Capacity in Pulmonary Arterial Hypertension
Enrollment Status: Completed
Publish Date: June 25, 2024
Intervention Type: Behavioral
Study Phase: Not Applicable
Bleeding Frequency Under Anticoagulant Treatment in Pulmonary Hypertension : HEMA-HTP Multicentric Study.
Bleeding Frequency Under Anticoagulant Treatment in Pulmonary Hypertension : HEMA-HTP Multicentric Study.
Enrollment Status: Completed
Publish Date: June 04, 2024
Intervention Type: Drug
EXADOM: Early Supported Discharge and Enhanced Homecare After Emergency Department Admission for Acute Exacerbation of Chronic Obstructive Pulmonary Disease
EXADOM: Early Supported Discharge and Enhanced Homecare After Emergency Department Admission for Acute Exacerbation of Chronic Obstructive Pulmonary Disease
Enrollment Status: Completed
Publish Date: May 14, 2024
Intervention Type: Other
Study Phase: Not Applicable
Circulating Tumor Cells and Early Diagnosis of Lung Cancer in Patients With Chronic Obstructive Pulmonary Disease
Circulating Tumor Cells and Early Diagnosis of Lung Cancer in Patients With Chronic Obstructive Pulmonary Disease
Enrollment Status: Completed
Publish Date: February 06, 2024
Intervention Type: Biological
Study Phase: Not Applicable
A Randomized Controlled Study of PneumRx Endobronchial Coil System Versus Standard-of-Care Medical Management in the Treatment of Subjects With Severe Emphysema
A Randomized Controlled Study of PneumRx Endobronchial Coil System Versus Standard-of-Care Medical Management in the Treatment of Subjects With Severe Emphysema
Enrollment Status: Completed
Publish Date: August 28, 2023
Intervention Type: Device
Study Phase: Not Applicable
Clinical Effectiveness and Economical Impact of Medical Indoor Environment Counselors Visiting Homes of Asthma Patients (ECENVIR Study)
Clinical Effectiveness and Economical Impact of Medical Indoor Environment Counselors Visiting Homes of Asthma Patients (ECENVIR Study)
Enrollment Status: Completed
Publish Date: May 24, 2023
Intervention Type: Other
Study Phase: Not Applicable
Impact of a Telemonitoring Program on the Rate of Hospitalizations for Worsening of Cardio-respiratory Symptoms in COPD Patients Treated at Home by Long-term Non-invasive Ventilation (NIV): a Randomized Controlled Trial
Impact of a Telemonitoring Program on the Rate of Hospitalizations for Worsening of Cardio-respiratory Symptoms in COPD Patients Treated at Home by Long-term Non-invasive Ventilation (NIV): a Randomized Controlled Trial
Enrollment Status: Terminated
Publish Date: April 24, 2023
Intervention Type: Other
Study Phase: Not Applicable
A Sequential Two Phase Multicenter, Randomized Study to Optimize Dose Selection and Evaluate Safety After Treatment With the Holaira™ Lung Denervation System in Patients With Moderate to Severe COPD.
A Sequential Two Phase Multicenter, Randomized Study to Optimize Dose Selection and Evaluate Safety After Treatment With the Holaira™ Lung Denervation System in Patients With Moderate to Severe COPD.
Enrollment Status: Completed
Publish Date: April 13, 2022
Intervention Type: Device
Study Phase: Not Applicable
A pRospective, Multicenter, Single-arm Study EvaLuating the Safety and feasIbility of Targeted Lung Denervation (TLD) for the trEatment oF Severe Asthma
A pRospective, Multicenter, Single-arm Study EvaLuating the Safety and feasIbility of Targeted Lung Denervation (TLD) for the trEatment oF Severe Asthma
Enrollment Status: Terminated
Publish Date: April 12, 2022
Intervention Type: Device
Study Phase: Not Applicable
Efficacy of Clarithromycin or Moxifloxacin Containing Regimen in 6 Months Sputum Conversion of Mycobacterium Xenopi
Efficacy of Clarithromycin or Moxifloxacin Containing Regimen in 6 Months Sputum Conversion of Mycobacterium Xenopi
Enrollment Status: Completed
Publish Date: July 20, 2020
Intervention Type: Drug
Study Phase: Phase 3
Feasibility at Home of a Rehabilitation Program Before Thoracic Surgery, for Pulmonary Parenchyma Exeresis
Feasibility at Home of a Rehabilitation Program Before Thoracic Surgery, for Pulmonary Parenchyma Exeresis
Enrollment Status: Completed
Publish Date: November 15, 2019
Intervention Type: Other
View 11 Less Clinical Trials

144 Total Publications

Improvement in severe asthma patients receiving biologics and factors associated with persistent insufficient control: a real-life national study.
Improvement in severe asthma patients receiving biologics and factors associated with persistent insufficient control: a real-life national study.
Journal: Therapeutic advances in respiratory disease
Published: November 15, 2023

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Pison's expertise for a condition
ConditionClose
View All 7 Advanced Conditions
View All 20 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile